Skip to main content
. 2015 Jan 24;17(6):801–809. doi: 10.1093/neuonc/nou363

Fig. 2.

Fig. 2.

Results of epigenetic qPCR determination of percent of CD3 frequency in brain tumor tissue from patients with glioblastoma (n = 23) and normal brain tissue from necropsy specimens (n = 20) showed a significant difference in infiltrating CD3 cells (P = .003).